Patient insights on living with idiopathic inflammatory myopathy and the limitations of disease activity measurement methods – a qualitative study

Overview of attention for article published in BMC Rheumatology, September 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#43 of 228)
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

policy: 1 policy source

twitter: 15 X users

Readers on

mendeley: 27 Mendeley

Summary Policy documents X

So far, Altmetric has seen 1 policy document that references this research output.

Alternative Therapies to Immunoglobulin for Idiopathic Inflammatory Myopathies

Cited by Canadian Agency for Drugs and Technologies in Health on 26 Jun 2023

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.